Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin

BACKGROUND: Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in the treatment of many cancers. However, doxorubicin posts a great risk of adverse cardiovascular events, which are thought to be caused by oxidative stress. We recently reported that the ubiquitin E3 ligase TRIM21 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Kai, Shen, Jianliang, Yan, Junrong, Zhai, Chuannan, Zhang, Jingxia, Pan, Ji-An, Zhang, Ye, Jiang, Yaping, Wang, Yongbo, Lin, Richard Z., Cong, Hongliang, Gao, Shenglan, Zong, Wei-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261003/
https://www.ncbi.nlm.nih.gov/pubmed/34233258
http://dx.doi.org/10.1016/j.ebiom.2021.103456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261003/
https://www.ncbi.nlm.nih.gov/pubmed/34233258
http://dx.doi.org/10.1016/j.ebiom.2021.103456

Ejemplares similares